Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Feature

Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023

Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Blog Editor: Tom Valuck, MD, JD

Anne DiSalvo, MPH, MBA; Kendall Logan...
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways
Research Reports
Off-Label Use of Precision Oncology Therapeutics in Advanced Solid Cancers Following Identification of Associated Variants via Multicancer Next-Generation Sequencing Panel: A Real-World Evidence Pilot Study
09/19/2023
Julie Wiedower, PhDc
Nicole Zhang, MPH
Rebecca Nagy, MS
Kathryn Lang, MD
Jayati Saha, PhD, MPH
Julie Wiedower, PhDc, and colleagues analyze the frequency of real-world off-label therapy utilization post–comprehensive genomic profiling via liquid biopsy in precision oncology.
Julie Wiedower, PhDc, and colleagues analyze the frequency of real-world off-label therapy utilization post–comprehensive genomic profiling via liquid biopsy in precision oncology.
Julie Wiedower, PhDc, and...
09/19/2023
Journal of Clinical Pathways

Advertisement

Review
NGS Testing in Non–Small Cell Lung Cancer
09/19/2023
Winston Wong, PharmD
Gordon Kuntz
Winston Wong, PharmD, and Gordon Kuntz provide an update on the current status of the research and barriers for using next-generation sequencing in NSCLC and summarize the discussion and next steps that the NGS Institute’s NSCLC Subcommittee...
Winston Wong, PharmD, and Gordon Kuntz provide an update on the current status of the research and barriers for using next-generation sequencing in NSCLC and summarize the discussion and next steps that the NGS Institute’s NSCLC Subcommittee...
Winston Wong, PharmD, and Gordon...
09/19/2023
Journal of Clinical Pathways
OCPC: IN SESSION
Artificial Intelligence in Oncology: The Wins, The Challenges, and How We Can Deliver on Personalized Cancer Care
09/19/2023
Matthew Biancalana, PhD
Tushar Pandey, MBA
Mathew Biancalana, PhD, and Tushar Pandey, MBA, discuss how artificial intelligence can enhance the field of precision medicine and help unburden physicians from laborious and repetitive tasks in diagnostic analyses.
Mathew Biancalana, PhD, and Tushar Pandey, MBA, discuss how artificial intelligence can enhance the field of precision medicine and help unburden physicians from laborious and repetitive tasks in diagnostic analyses.
Mathew Biancalana, PhD, and...
09/19/2023
Journal of Clinical Pathways
Research Reports
Oncology Pathways Drive Adoption of High-Quality Treatment Regimens and Deliver Drug Cost Savings
08/07/2023
Kathryn Christensen, MS
Timothy Dollear, MD
Rama Al Ghannam, PharmD
Eric Gratias, MD, FAAP
Robinson Ortiz, MD
Stephen Hamilton, MD
Kathryn Christensen, MS, and colleagues share the initial results of the launch of Cigna and eviCore Healthcare’s Oncology Value-based Pathways program.
Kathryn Christensen, MS, and colleagues share the initial results of the launch of Cigna and eviCore Healthcare’s Oncology Value-based Pathways program.
Kathryn Christensen, MS, and...
08/07/2023
Journal of Clinical Pathways

Advertisement

Perspectives
Leveraging Quality Measurement to Drive Equitable Cancer Care for Transgender Individuals
08/07/2023
Elizabeth Donckels, MSPH
Nina Regenold, MSc
Theresa Schmidt, MA
Will Nolan
Scout
Don S. Dizon, MD
Tom Valuck, MD, JD
Elizabeth Donckels, MSPH, and colleagues investigate several measurement tactics to promote cancer care quality improvement for transgender individuals.
Elizabeth Donckels, MSPH, and colleagues investigate several measurement tactics to promote cancer care quality improvement for transgender individuals.
Elizabeth Donckels, MSPH, and...
08/07/2023
Journal of Clinical Pathways
Research Reports
Can We Fill in the Gaps? Authoring Custom Oncology Pathways vs Surfacing NCCN Preferred Recommendations Alone
06/05/2023
Rebecca Maniago, PharmD, BCOP
Marcello Ricottone
Gregory S. Calip, PharmD, MPH, PhD
Taylor Dias-Foundas
James Hamrick, MD, MPH
Rebecca Maniago, PharmD, and colleagues compare the overall availability of NCCN Preferred recommendations to custom preferred pathways and assess provider concordance with the preferred suggestions, particularly those encountered in the...
Rebecca Maniago, PharmD, and colleagues compare the overall availability of NCCN Preferred recommendations to custom preferred pathways and assess provider concordance with the preferred suggestions, particularly those encountered in the...
Rebecca Maniago, PharmD, and...
06/05/2023
Journal of Clinical Pathways
Research Reports
Treatment Duration, Adherence, Interruptions, and Discontinuations Associated With Maintenance Regimens for Recurrent Ovarian Cancer
06/05/2023
Emma L. Barber, MD
Allison M. Saiz, MD
Nicole M. Engel-Nitz, PhD
Scott H. Bunner, MPH
Katrine L. Wallace, PhD
Emma L. Barber, MD, and colleagues investigate current and real-world practice patterns for patients receiving maintenance therapy for recurrent ovarian cancer after second-line chemotherapy.
Emma L. Barber, MD, and colleagues investigate current and real-world practice patterns for patients receiving maintenance therapy for recurrent ovarian cancer after second-line chemotherapy.
Emma L. Barber, MD, and...
06/05/2023
Journal of Clinical Pathways

Advertisement

Research Reports
Pegfilgrastim Home Redirection Outcomes: Effectiveness and Timing of Administration in Primary Prophylaxis of Chemotherapy-Induced Neutropenia
06/05/2023
Lavanya Raj, MBBS, MS
Pam McManus
Lavanya Raj, MBBS, MS, and Pam McManus summarize the impact of Cigna’s site-of-care home-redirection program on pegfilgrastim effectiveness and the timing of administration in preventing complications from chemotherapy-induced neutropenia...
Lavanya Raj, MBBS, MS, and Pam McManus summarize the impact of Cigna’s site-of-care home-redirection program on pegfilgrastim effectiveness and the timing of administration in preventing complications from chemotherapy-induced neutropenia...
Lavanya Raj, MBBS, MS, and Pam...
06/05/2023
Journal of Clinical Pathways
Research Reports
Bone-Modifying Agent Utilization: An Analysis in Patients With Metastatic Cancer and Bone Involvement at an NCI-Designated Cancer Center
04/12/2023
Poorni M. Manohar, MD
Kyle E. Bastys
Micah Tratt
Julie Gralow, MD, FACP, FASCO
Keith D. Eaton, MD, PhD
Manohar et al investigate the cost of utilizing bone-modifying agents in the treatment of patients with metastatic cancer and bone involvement at a National Cancer Institute–designated cancer center.
Manohar et al investigate the cost of utilizing bone-modifying agents in the treatment of patients with metastatic cancer and bone involvement at a National Cancer Institute–designated cancer center.
Manohar et al investigate the...
04/12/2023
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use